SBIO
Fund Stats as of 01/19/2018
Symbol SBIO
CUSIP 00162Q 593
ISIN US00162Q5936
Inception Date 12/30/2014
Dividends Paid Annual
Fund Type Exchange Traded Fund
Market Price $34.83
Last Trade Price $34.84
NAV $34.80
NAV Change $0.61
Total Net Assets $151,398,288
Total Market Value $151,423,792
Premium/Discount(%) 0.09%
Difference ($) $0.03
Volume 40,078
Shares Outstanding 4,350,000
Expenses as of 03/31/2017
Management Fee0.50%
Other Expenses0.00%
Total Operating Expenses0.50%
Fund Resources
Summary Prospectus 
Statement of Additional Information 
Quarterly Fact Sheet 
Statutory Prospectus 
Resource Library  

Daily Fund Holdings 98 total, as of 01/19/2018, subject to change

SecuritySymbolWeight
Galapagos NVGLPG4.33%
BeiGene Ltd.BGNE3.88%
Taro Pharmaceutical Industries Ltd.TARO3.23%
Akorn Inc.AKRX3.13%
Sarepta Therapeutics Inc.SRPT3.06%
FibroGen Inc.FGEN2.97%
TESARO Inc.TSRO2.63%
Agios Pharmaceuticals Inc.AGIO2.55%
GW Pharmaceuticals PLCGWPH2.54%
Ligand Pharmaceuticals Inc.LGND2.49%
Portola Pharmaceuticals Inc.PTLA2.45%
Loxo Oncology Inc.LOXO2.19%
Clovis Oncology Inc.CLVS2.11%
AnaptysBio Inc.ANAB2.05%
Array BioPharma Inc.ARRY1.96%
Halozyme Therapeutics Inc.HALO1.94%
Horizon Pharma PLCHZNP1.87%
Immunomedics Inc.IMMU1.84%
Supernus Pharmaceuticals Inc.SUPN1.82%
Global Blood Therapeutics Inc.GBT1.79%
Insmed Inc.INSM1.70%
Aerie Pharmaceuticals Inc.AERI1.65%
Emergent BioSolutions Inc.EBS1.61%
Ironwood Pharmaceuticals Inc.IRWD1.58%
Aimmune Therapeutics Inc.AIMT1.50%
Acceleron Pharma Inc.XLRN1.48%
MyoKardia Inc.MYOK1.46%
Ascendis Pharma ASASND1.42%
Spark Therapeutics Inc.ONCE1.42%
Radius Health Inc.RDUS1.29%
Endo International PLCENDP1.20%
Pacira Pharmaceuticals Inc.PCRX1.19%
Madrigal Pharmaceuticals Inc.MDGL1.18%
Theravance Biopharma Inc.TBPH1.16%
Impax Laboratories Inc.IPXL1.13%
Arena Pharmaceuticals Inc.ARNA1.06%
Enanta Pharmaceuticals Inc.ENTA0.97%
Acorda Therapeutics Inc.ACOR0.96%
Heron Therapeutics Inc.HRTX0.96%
DBV Technologies SADBVT0.95%
ImmunoGen Inc.IMGN0.81%
Amarin Corp. PLCAMRN0.81%
Epizyme Inc.EPZM0.80%
Revance Therapeutics Inc.RVNC0.80%
Athenex Inc.ATNX0.76%
Dynavax Technologies Corp.DVAX0.72%
PTC Therapeutics Inc.PTCT0.69%
Atara Biotherapeutics Inc.ATRA0.68%
Flexion Therapeutics Inc.FLXN0.67%
Adamas Pharmaceuticals Inc.ADMS0.66%
Lannett Co. Inc.LCI0.66%
Sucampo Pharmaceuticals Inc.SCMP0.63%
GlycoMimetics Inc.GLYC0.61%
Aclaris Therapeutics Inc.ACRS0.57%
G1 Therapeutics Inc.GTHX0.57%
Adaptimmune Therapeutics PLCADAP0.57%
Rhythm Pharmaceuticals Inc.RYTM0.55%
Jounce Therapeutics Inc.JNCE0.53%
Akebia Therapeutics Inc.AKBA0.53%
NuCana PLCNCNA0.50%
Five Prime Therapeutics Inc.FPRX0.48%
Reata Pharmaceuticals Inc.RETA0.45%
UroGen Pharma Ltd.URGN0.43%
BioCryst Pharmaceuticals Inc.BCRX0.42%
Kura Oncology Inc.KURA0.41%
Aduro Biotech Inc.ADRO0.41%
Clementia Pharmaceuticals Inc.CMTA0.40%
AMAG Pharmaceuticals Inc.AMAG0.37%
Depomed Inc.DEPO0.37%
Arrowhead Pharmaceuticals Inc.ARWR0.36%
Concert Pharmaceuticals Inc.CNCE0.34%
Paratek Pharmaceuticals Inc.PRTK0.34%
Avadel Pharmaceuticals PLCAVDL0.33%
Progenics Pharmaceuticals Inc.PGNX0.33%
PDL BioPharma Inc.PDLI0.33%
Seres Therapeutics Inc.MCRB0.32%
Achillion Pharmaceuticals Inc.ACHN0.31%
Savara Inc.SVRA0.30%
Protagonist Therapeutics Inc.PTGX0.29%
Catalyst Pharmaceuticals Inc.CPRX0.29%
NantKwest Inc.NK0.26%
Molecular Templates Inc.MTEM0.24%
Calithera Biosciences Inc.CALA0.23%
Tocagen Inc.TOCA0.21%
Aquinox Pharmaceuticals Inc.AQXP0.21%
XOMA Corp.XOMA0.21%
MediciNova Inc.MNOV0.20%
Minerva Neurosciences Inc.NERV0.20%
Syndax PharmaceuticSNDX0.19%
Chimerix Inc.CMRX0.18%
Vascular Biogenics Ltd.VBLT0.17%
Selecta Biosciences Inc.SELB0.16%
Cascadian Therapeutics Inc.CASC0.16%
Ra Pharmaceuticals Inc.RARX0.14%
Zynerba Pharmaceuticals Inc.ZYNE0.12%
Dyax Corp. - CVRDYAX-CVR0.00%
State Street Institutional Treasury Plus Money Market FundTPIXX0.03%
Cash and Equivalents-0.01%
Total Net Assets 100.00%
Security
Galapagos NV
BeiGene Ltd.
Taro Pharmaceutical Industries Ltd.
Akorn Inc.
Sarepta Therapeutics Inc.
FibroGen Inc.
TESARO Inc.
Agios Pharmaceuticals Inc.
GW Pharmaceuticals PLC
Ligand Pharmaceuticals Inc.
Portola Pharmaceuticals Inc.
Loxo Oncology Inc.
Clovis Oncology Inc.
AnaptysBio Inc.
Array BioPharma Inc.
Halozyme Therapeutics Inc.
Horizon Pharma PLC
Immunomedics Inc.
Supernus Pharmaceuticals Inc.
Global Blood Therapeutics Inc.
Insmed Inc.
Aerie Pharmaceuticals Inc.
Emergent BioSolutions Inc.
Ironwood Pharmaceuticals Inc.
Aimmune Therapeutics Inc.
Acceleron Pharma Inc.
MyoKardia Inc.
Ascendis Pharma AS
Spark Therapeutics Inc.
Radius Health Inc.
Endo International PLC
Pacira Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc.
Theravance Biopharma Inc.
Impax Laboratories Inc.
Arena Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Acorda Therapeutics Inc.
Heron Therapeutics Inc.
DBV Technologies SA
ImmunoGen Inc.
Amarin Corp. PLC
Epizyme Inc.
Revance Therapeutics Inc.
Athenex Inc.
Dynavax Technologies Corp.
PTC Therapeutics Inc.
Atara Biotherapeutics Inc.
Flexion Therapeutics Inc.
Adamas Pharmaceuticals Inc.
Lannett Co. Inc.
Sucampo Pharmaceuticals Inc.
GlycoMimetics Inc.
Aclaris Therapeutics Inc.
G1 Therapeutics Inc.
Adaptimmune Therapeutics PLC
Rhythm Pharmaceuticals Inc.
Jounce Therapeutics Inc.
Akebia Therapeutics Inc.
NuCana PLC
Five Prime Therapeutics Inc.
Reata Pharmaceuticals Inc.
UroGen Pharma Ltd.
BioCryst Pharmaceuticals Inc.
Kura Oncology Inc.
Aduro Biotech Inc.
Clementia Pharmaceuticals Inc.
AMAG Pharmaceuticals Inc.
Depomed Inc.
Arrowhead Pharmaceuticals Inc.
Concert Pharmaceuticals Inc.
Paratek Pharmaceuticals Inc.
Avadel Pharmaceuticals PLC
Progenics Pharmaceuticals Inc.
PDL BioPharma Inc.
Seres Therapeutics Inc.
Achillion Pharmaceuticals Inc.
Savara Inc.
Protagonist Therapeutics Inc.
Catalyst Pharmaceuticals Inc.
NantKwest Inc.
Molecular Templates Inc.
Calithera Biosciences Inc.
Tocagen Inc.
Aquinox Pharmaceuticals Inc.
XOMA Corp.
MediciNova Inc.
Minerva Neurosciences Inc.
Syndax Pharmaceutic
Chimerix Inc.
Vascular Biogenics Ltd.
Selecta Biosciences Inc.
Cascadian Therapeutics Inc.
Ra Pharmaceuticals Inc.
Zynerba Pharmaceuticals Inc.
Dyax Corp. - CVR
State Street Institutional Treasury Plus Money Market Fund
Cash and Equivalents
Total Net Assets